Premium Nahrungsergänzungsmittel | artgerecht

Red Blood Cell Concentrate – Definition and Use

A red blood cell concentrate is a blood product containing red blood cells, used to treat anemia or significant blood loss through transfusion.

Regular tips about health Regular tips about health

Things worth knowing about "Red Blood Cell Concentrate"

A red blood cell concentrate is a blood product containing red blood cells, used to treat anemia or significant blood loss through transfusion.

What is a Red Blood Cell Concentrate?

A red blood cell concentrate (RBC concentrate) is a blood product derived from donated whole blood. It consists primarily of red blood cells (erythrocytes), which are responsible for transporting oxygen throughout the body. During production, most of the plasma and platelets are removed. RBC concentrates are among the most commonly used blood products in clinical medicine worldwide.

Production and Properties

RBC concentrates are produced by centrifuging whole blood donated by voluntary donors. The red blood cells are separated from plasma and white blood cells (leukocytes). In most countries, RBC concentrates are routinely leukocyte-depleted using special filters to minimize transfusion reactions. A standard unit has a volume of approximately 250 to 350 ml and can be stored at 2 to 6 degrees Celsius for up to 42 days.

Indications – When is a Red Blood Cell Concentrate Used?

An RBC concentrate is transfused when the body cannot transport sufficient oxygen due to a low number or poorly functioning red blood cells. Common indications include:

Acute blood loss, such as in trauma or surgery
Chronic anemia, for example due to cancer, chronic kidney disease, or gastrointestinal disorders
Hemolytic anemia, where red blood cells are prematurely destroyed
Aplastic anemia, where the bone marrow fails to produce adequate blood cells
Severe anemia related to thalassemia or sickle cell disease

The decision to transfuse is based on the patient's hemoglobin (Hb) level and overall clinical condition. Current guidelines generally recommend transfusion when the Hb level falls below 7 g/dl.

Mechanism of Action and Benefits

Red blood cells contain hemoglobin, an iron-containing protein that picks up oxygen in the lungs and delivers it to tissues throughout the body. Transfusing an RBC concentrate rapidly increases the blood's oxygen-carrying capacity. This can be life-saving in cases of severe blood loss and can relieve symptoms of chronic anemia such as fatigue, shortness of breath, and dizziness.

How is a Transfusion Performed?

Before every transfusion, blood group typing and a crossmatch test (compatibility testing) are required to ensure the blood product is compatible with the recipient. The transfusion is administered intravenously through a peripheral or central venous catheter and typically takes 60 to 120 minutes per unit. During the transfusion, vital signs such as blood pressure, pulse, and temperature are closely monitored.

Risks and Side Effects

RBC concentrates are generally very safe, but side effects can occur:

Febrile non-hemolytic transfusion reaction: Fever and chills during or shortly after the transfusion
Allergic reactions: Ranging from mild urticaria (hives) to severe anaphylaxis
Hemolytic transfusion reaction: Destruction of transfused red blood cells by the recipient's antibodies – potentially life-threatening
Transfusion-associated circulatory overload (TACO): Excess fluid causing pulmonary edema
Transfusion-related acute lung injury (TRALI): A rare but serious lung reaction
Transmission of infectious diseases: Extremely rare due to comprehensive screening procedures

Special Types of Red Blood Cell Concentrates

Depending on clinical needs, specially prepared forms are available:

Irradiated RBC concentrates: Gamma or X-ray irradiation prevents graft-versus-host disease in immunocompromised patients
Washed RBC concentrates: Plasma is removed, for example in patients with IgA deficiency or severe allergic reactions
CMV-negative RBC concentrates: Used for immunocompromised patients and pregnant women to prevent cytomegalovirus transmission

References

Mueller M.M. et al. – Patient Blood Management: Recommendations from the 2018 Frankfurt Consensus Conference. JAMA, 2019;321(10):983–997.
Carson J.L. et al. – Red Blood Cell Transfusion: 2023 AABB International Guidelines. JAMA, 2023;330(19):1892–1902.
World Health Organization (WHO) – Blood Safety and Availability. Fact Sheet (2023). Available at: https://www.who.int/news-room/fact-sheets/detail/blood-safety-and-availability

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.